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Male circumcision as HIV prevention between controversies and scientific investigation 
 
Geneviève Harrous-Paicheler 
CNRS. CERMES3 UMR 8211 
 
Abstract 
The randomized controlled trial (RCT) is considered the scientific foundation of medical practice in 
evidence based medicine. Therefore, the evidence it brings should put an end to controversies. But this 
was not the case if we look at the demonstration of the protective role of male circumcision (MC) 
against HIV/AIDS infection. Although based on a series of epidemiological investigations, 
culminating in RCTs, the benefits of MC are a controversial subject in the medical and scientific 
community. The RCTs are considered too reductionist; they allow for control during the investigation 
but are divorced from real-life conditions. In fact, evidence appears as a social construction, relying on 
more than objective factors, sometimes prejudices and misconceptions. Articles published on MC in 
scientific journals over nearly two decades and the reactions they elicited, both inside and outside the 
medical community are analysed. Data produced within RCTs have been criticized, notably for the 
gap between efficacy and effectiveness, experimentation and experience. Even though it is reduced, 
uncertainty is not dispelled by RCTs. In any case, this does not influence the scaling up of MC, which 
depends on both scientific evidence and the personal beliefs of the actors —researchers, decision-
makers and the public. 
 





Medicine is as much empirical knowledge as experimental science. It must describe the experience of 
illness as well as the individual variations that characterize it. Reality, which gives rise to experience, 
is considered deceptive. Personal experience, even a long series of converging experiences, has no 
value for establishing evidence. The statistical methods of epidemiology aim at neutralizing the 
variability of data. Only randomised controlled trials (RCT) and their methodological arsenal, freed 
from the contingencies of real life, can make a decisive contribution. Quasi-experimental methods are 
substituted for observation, by comparing groups according to controlled variables. But it remains 
impossible to control all the possible variables and questions are raised about those variables escaping 
control.  
From descriptive to prospective epidemiology, then to RCTs, the goal of medical research is to 
exercise increasing control over empirical phenomena, the individual experiences of illness, in order to 
untangle a jumble of unstable facts (Fleck, 1981). Ultimately, it is the consensus among the 
researchers with regard to the framework of analysis, the methodological tools and the results that 
confers reliability and legitimacy on the evidence. Therefore, “integrating evidence is invariably a 
subjective process, dependant on the skills and values of the individuals who are trying to synthesize 
multiples pieces of diverse medical evidence” (Mulrow & Lohr, 2001, 257). 
In evidence-based medicine (EBM), a higher level in the scientific process is reached. "Evidence was 
to be the practical form in which science entered into clinical consideration" (Daly, 2005, 12). There is 
no longer direct contact between a clinician and her patient, but rather an anonymous framework that 
allows the elimination of subjective factors and intrusive interactions in order to attain that ideal: an 
"impersonal standard of scientific integrity" (Marks, 1997, 3). Challenging consensus-based 
judgments, the RCT is supposed to provide an indisputable explanation. It aims at “a move from 
eminence-based decisions to evidence-based decisions” (Eisenberg, 2001, 371). It is the culmination 
of a rigorous methodology based on the careful and critical examination of articles published in peer-
reviewed journals and on reviews of the research literature. However, proponents of EBM are 
themselves aware of its limits. “The greater conceptual hurdle is to generate a science appropriate for 
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the whole of clinical practice, in all its complexity, including the social and political context of 
patients and the health care system” (Daly, 2005, 2). As are its opponents :" the quantitative, 
essentially epidemiological definition of evidence in EBM was most often identified as 
problematically restrictive" (Lambert, 2006, 2640). 
Framed by its hypotheses, its variables and its methods, the RCT leaves aside a whole series of 
phenomena. "Even the simplest RCT is the product of a negotiated order, replete with decisions —
some contested, some not— and unexamined assumptions" (Marks, 1997, 134). Clinical research is a 
social enterprise, even a power struggle, "an activity conducted in a manner similar to politics, by 
groups of individuals with differing beliefs and interests, who must somehow persuade one another to 
enter into a temporary and partial alliance, and who then either succeed or fail to persuade others to act 
in concert with them" (ibid., 243). In contrast to a functional view of scientific demonstration, there 
are critics who emphasize the temporal and relative nature of evidence, a social construction as much 
as a scientific one (Berkvits, 1998; Dobrow et al., 2004).  
Science advances through a collective effort based on the “style of thought” of a scientific community 
(Fleck, 1981). In the process of demonstrating the protective role of male circumcision (MC) against 
HIV infection, we can trace the increasing complexity of approaches that follows the hierarchy of 
evidence used in EBM (Mulrow & Lohr, 2001). Then, as data accumulate, there is a decrease in 
differences between various methods and explanatory frameworks following the elimination of 
artifacts and intrusive hypotheses.  
It has been long observed that the prevalence of HIV/AIDS infection in African countries is inversely 
proportional to the frequency of MC. But it took more than two decades for that relationship to be 
scientifically proven. An RCT showed that it protects men from getting HIV (Auvert et al., 2005) and 
this result was confirmed by two other RCTs (Bailey et al., 2007; Gray et al. 2007). These data have 
been questioned. While MC is one of the oldest surgical operations in the world, it remains highly 
controversial. Where some people identify an effective and definitive means for avoiding sexually 
transmitted diseases, other see useless surgery, unacceptable mutilation, both barbarous and 
reactionary, a religious or cultural heritage and an endeavour of puritans opposed to sexual 
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satisfaction. The hypothesis that MC protects against HIV infection came to light in 1986. And it was 
only some twenty years later in 2005 that the first RCT was published showing that it protected men 
from the risk of HIV infection. Twenty years to unravel the tangle of hypotheses, counter-hypotheses, 
confirmations, refutations; twenty years of impassioned debate. Here, I will retrace the steps taken 
during two decades of research, emphasizing the complex intermingling of scientific investigation and 
social factors. An examination of the nature of evidence in a scientific project —the process of 
demonstration of the preventive role of MC—constitutes the central theme of this article. 
Methodology 
I undertook a search of medical and scientific peer-reviewed journals for articles about MC as 
potential HIV prevention in Africa and for letters that comment on them. The Pubmed, Medscape, 
Embase, Aidsline databases, as well as the databases of identified journals, were searched. All articles 
used statistical methods. Comments on published articles have a different status; they do not rely on 
scientific investigation, have not been peer reviewed and can express opinions. The correspondence 
sections offer space for debate. The retrieved articles and letters were categorized manually to capture 
the range of comments, arguments and critics. My review seeks to follow the research process that had 
led to carrying out RCTs —a process based on arguments and counter-arguments relative to MC— 
and then to examine the reactions to these RCTs. It does not encompass their scientific reliability nor 
the appropriateness of methods used1. Using a sociological approach, it concerns their discourse, their 
objectives and conclusions, as they are stated by the authors.  
The randomized controlled trials  
A RCT carried out between 2002 and 2005 in South Africa found evidence of the protective effect of 
MC (Auvert et al., 2005). It was terminated early during an intermediary analysis by an independent 
committee because the results were judged so positive that it would not have been ethical to continue 
depriving half of the 3274 participants of the benefits of MC, if they wished to undergo it. HIV-
negative participants, aged 18 to 24 years, were randomly divided into two groups, half being 
                                                      
1 Analyses of the internal validity of the research projects are found in the literature and integrated into our 
approach. 
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circumcised at the start of the research. All volunteers received information on HIV prevention and 
other sexually transmitted diseases, as well as free condoms2. They were followed up at regular 
intervals in order to verify that sexual behaviours were comparable in the two groups. When the 
research was interrupted, 20 circumcised participants were HIV infected against 49 uncircumcised 
ones, giving a 60% rate of protection. 
In view of these results, WHO and UNAIDS remained cautious and awaited confirmation by two 
similar research projects carried out in Kenya (Bailey et al., 2007) and in Uganda (Gray et al., 2007) 
before deciding on a prevention policy. These two trials were also terminated early and confirmed the 
prophylactic function of MC. The trial carried out at Kisumi in Kenya followed a similar procedure 
and obtained results very close to those of Auvert et al. (2005). The trial carried out at Rakai in 
Uganda (Gray et al., 2007) on 4996 men is similar to the preceding ones, except for the wider age 
range studied (15-49 years). Depending on the way data are analyzed, the preventive efficacy of MC 
varied from 51% to 60%. The results of these RCTs are remarkably similar. Their authors thus 
recommend the practice of MC in populations where that practice is rare and where high transmission 
rates of HIV are mainly attributable to heterosexual contacts. They also emphasize that protection is 
only partial and that information is needed in order to avoid a slackening of preventive behaviours. 
These RCTs produced their results after nearly two decades of intense discussions on the protective 
role of MC against HIV, which I will now examine. 
The antecedents 
Biological foundations 
In 1986, Fink and Alcena assumed a link between HIV infection and absence of MC. “Because the 
majority of men from Central Africa are not circumcised,…there is frequent mini-ulceration of the 
foreskin of the penis. This represents an easy portal of entry for the virus…” (Alcena, 1986, 446)3. The 
biological basis for MC protection was described later by Szabo and Short (2000): the foreskin 
                                                      
2 As in the following two RCTs, the ethical aspects of the investigation were carefully taken into consideration 
(Cleaton-Jones, 2005). 
3 Citation pages will not be mentioned when the articles were published or reproduced on Internet sites without 
mention of a page number. 
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contains more Langerhans target cells for HIV. By reducing the surface of the foreskin, MC reduces 
these target cells. Atashili (2006) disputes the evidence and states that the foreskin has an 
immunological function as MC does not get rid of all the target cells.  
Converging evidence: Observations on the protective function of MC 
Although indigenous African healers recommend MC for protection against sexually transmitted 
infections (Green et al., 1993), the first epidemiological studies on the distribution of HIV infection in 
Africa found contrasting situations (Moses et al., 1990). The main question was to find out if these 
were attributable to MC. This was the purpose of more than forty observational studies. In an 
approximate study of 409 African ethnic groups, Bongaarts et al. (1989) concluded that MC provided 
an explanation for the disparity of HIV prevalence in Africa. Cameron et al. (1989) used a prospective 
methodology and confirmed the link between the absence of MC, genital ulcers — two interrelated 
factors — and HIV infection, studying prostitutes with a 85% HIV-prevalence and their clients.  
Data on MC were synthesized in review articles. Analyzing a series of observational studies, Caldwell 
and Caldwell (1994) emphasized the polemical aspect of this question. “The role of male non-
circumcision has been presented in epidemiological studies which claimed a level of statistical 
association usually accepted as approaching proof in other investigations. These studies have been 
largely ignored for reasons that may not be entirely scientific.” (23). Moses et al. (1994) reviewed 30 
observational studies: out of 26 cross-sectional studies4, 18 showed an association between MC and 
lower risk. They stressed the reliability of the data. “Most of the Bradford-Hill criteria of causation are 
met: strength of association, consistency, temporality, biologic gradient and theoretical plausibility, 
coherence, analogy” (207). They dismissed an objection often cited by opponents of MC: the spread of 
the infection in Africa because of contaminated blood.  
In a study of 837 married men in Rwanda (Seed et al., 1995), the men living in rural areas, mostly 
uncircumcised and supposedly less exposed to HIV risk had a higher rate of HIV infection than the 
men living in urban areas, mostly circumcised. New confirmation of data in favor of MC was reported 
                                                      
4 Cross-sectional studies provide a "snapshot" of the frequency of a disease in a population at a 
particular point in time. 
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in a prospective research on trucking company employees (Lavreys et al., 1999) where the 
circumcision status was verified by physical examination5. The uncircumcised men had a 4-fold 
increased risk of HIV infection. 
Halperin and Bailey (1999) reviewed ten years of studies on the association between MC and HIV 
infection. They concluded that “it is time for the international health community to add MC services to 
the current limited armamentarium of AIDS prevention measures in countries with a high prevalence 
of heterosexually transmitted HIV and STDs… [Otherwise] medical professionals and public health 
authorities may inadvertently be harming the very individuals whom they are trying to help” (1814). 
Two articles compared the prevalence of HIV infection in four African cities that had contrasting rates 
of HIV infection: moderate in Cameroon and Benin or very high in Kenya and Zambia (Auvert et al. 
2001). Data analyses controlled for confounding factors such as religious, cultural practices, sexual 
behaviours, and confirmed the population level association between HIV and lack of MC.  
Agot et al. (2004) used a rigorous methodology to confirm that MC is associated with reduced risk of 
acquiring HIV among men. A serology test for HIV was carried out on two groups of Luo men from 
Kenya for whom HIV infection was analyzed in relation to the presence or absence of MC, verified by 
medical examination. But according to Franco (2004), that research did not enable the debate to 
progress, even though its authors had made great efforts at “disentangling the possible biological 
effects of circumcision from its inextricable links to religious beliefs, cultural factors and sexual 
practices” (134). While data in favour of MC were accumulating, the question of its acceptability was 
was investigated among various sub-Saharan African populations where the practice was not 
widespread. In a review of this question, Westercamp and Bailey (2007) concluded: “it is doubtful 
… that we learn a great deal more by additional acceptability studies that pose hypothetical questions 
to participants” (353).  
Doubts and caution 
Discordant opinions were voiced. In a review article, Vincenzi and Mertens (1994) expressed several 
criticisms that were picked up and amplified in numerous subsequent publications. They contested the 
                                                      
5 Commonly used in the preceding studies, self report is less reliable. 
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biological plausibility of MC: “it is unclear what the portal of entry is for HIV” (156). Data were 
judged heterogeneous and contradictory, lacking a coherent explanatory model. They cited numerous 
biases: hygiene practices, sexual behaviour, misclassification of exposure, reliability of self-reports, 
and also a supposed “publication bias” in favour of articles positive to MC. Finally, they wondered if 
the interpretation of the data relied on “faith6 or evidence”. Rather, the effects of MC should be subject 
to an objective scientific analysis and not be debated in an impassioned and emotional fashion, they 
conclude, after throwing oil on the fire of subjectivity. 
Reservations were voiced in several epidemiological studies and reviews that confirmed the beneficial 
effects of MC (O'Farrell & Egger, 2000; Weiss et al., 2000). Resistance to HIV infection could be due 
to religious proscriptions and strict rules of hygiene that affected risk. A cohort study was carried out 
on 5507 seronegative men and 410 serodifferent couples (Gray et al., 2000). The data were confusing 
because a part of the participants was Muslim. The results of a national study in South Africa 
(Connolly et al., 2008) confirmed that MC does not protect against AIDS when it is practiced too late, 
on sexually active adults and outside a medical setting.  
Reviews looked at confounding factors (Bailey, Plummers & Moses, 2001; Hayes, 2001; Quigley, 
Weiss & Hayes, 2001) and concluded that data in favor of MC were not sufficiently convincing. A 
series of questions were raised, notably, the types of MC, its protection against other sexually 
transmitted infections, the reasons for practicing MC, the impact of the age at which it is carried out, 
and its scientific foundations. In a letter reacting to an article favourable to MC by Halperin et al. 
(2002), Gray et al. (2002) recommend caution and the setting up of RCTs. To which the former reply 
by evoking mounting biological evidence. A Cochrane review7 was carried out (Siegfried et al., 2003) 
emphasized  the methodological heterogeneity of the studies, as well as their inconsistent quality, and 
concluded that “there is no strong evidence of the effects of male circumcision to try to reduce the 
spread of HIV/AIDS”. “…Observational studies are inherently limited by confounding which is 
                                                      
6 The use of this word doubtless relates to the religious dimension of MC, not mentioned directly here. 
7 The Cochrane collaboration aims to be a global resource for systematic review and a critical appraisal of 
research articles. Set up by experts according to a highly codified procedure, Cochrane reviews are a basic 
reference. 
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unlikely to be fully adjusted for.” It was necessary to await results of RCTs before promoting MC in 
Africa.  
Publications on MC are characterized by repetition: researchers redo similar investigations and 
analysis and come to similar conclusions. Redundancy is the rule, even if it is not easily discernible 
because publications appear in diverse formats — journals specializing or not in HIV infection — and 
do not reach the same audience. 
The offensive against MC: the denunciation of a conspiracy 
The issue of MC was caught between studies that attempted to untangle cause from effect on one hand 
and stubborn resistance, on the other. Opponents of MC expressed their viewpoint mainly in letters in 
reaction to published scientific articles and in websites. Van Howe (1999) considered MC as 
scientifically unfounded and dangerous. He denied that studies carried out in Africa shown that 
circumcised men were less exposed to HIV risk: they supposedly have more partners and condoms did 
not stay on their penises. Darby (2004) repeated the usual methodological arguments: selection bias, 
religion as a confounding variable, inadequate statistical analysis. Boyle (2004) evoked the fact that 
the approach used by researchers, themselves supposedly circumcised, —if this was the case he 
prudently added— was biased. Thus, researchers were accused of abusive proselytizing.  
Szabo and Short’s (2000) biological arguments were attributed to a retrograde and puritanical 
Victorian period, to backward tribal customs, to hundred years of pressure by circumcisers playing on 
fears. The foreskin could not have been an "error of nature", i.e. of God (Cruz, 2000). According to 
Van Howe et al. (2000), “HIV transmission is heavily dependent on certain sexual behaviours, not 
anatomy” (1467). The criticized authors condemned their opponents’ dogmatic position. “It would be 
unfortunate if the zealous opponents of neonatal male circumcision in developed countries… 
distracted attention from the glaring fact that in Central and Southern Africa, where 24.5 million 
people are infected with HIV, circumcision could offer some immediate protection against spread of 
the disease” (Szabo & Short, 2000, 1594). 
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Boyle (2003) described numerous negative effects of MC. It provokes an “emotional defence against 
(one's) own painful feelings of grief for a lost body part and reduced sexual function” (427). The 
catalogue of these undesirable effects was eclectic: unhappiness, anger, sadness, feeling incomplete, 
cheated, hurt, concerned, frustrated, abnormal, and violated. The circumcised  men would be prone to 
alcohol dependence and the use of drugs, as well as solitude, marital problems, anti-social behaviours, 
domestic violence, rape, sexual abuse of children, theft and suicide. In front of this bleak picture, the 
practice of MC is described as “wishful fantasy” provoking “a calamitous worsening of the HIV/AIDS 
epidemic” (328). For Hill and Denniston (2003), 90% of the sub-Saharan African epidemic was not 
due to heterosexual transmission as only 30% of infections were attributable to sexual activity. The 
other infections would be due to iatrogenic transmission through blood that could only be increased by 
MC practiced under poor hygienic conditions. Besides, MC could change sexual behaviours by 
increasing risky practices. The authors raised the threat of what “Africans” or “African males” may 
think or do, “abused and exploited by scientists who recommend the circumcision policy, sensitive of 
previous colonial exploitation and suspicious of the biological warfare origin of the virus” (496)8. 
They warned against the political consequences of the probable failure of MC: “African males would 
have sacrificed their erogenous tissue for a false hope of preventing HIV infection”(ibid.). 
As more evidence accumulated in favour of MC, the criticisms became more caustic. For Hellsten 
(2004) 9, MC, a "genital mutilation", absurd and irrational, would open the door to allowing all sorts of 
mutilations: “We would have no justification for stopping (parents) cutting off their children’s ears, 
fingers or noses if their religion or cultural beliefs demand it”. MC would bring about “a sexual 
disinhibition, and for women, unsafe, maybe also forced, sex”. The reasons to practice MC were a 
“mere smokescreen10 to cover up the actual social, political or economic reasons that are behind the 
preservation of genital mutilation in any given cultural context”. A conspiracy was denounced. 
“Medical data with counter results [are] ignored or misinterpreted in order to maintain the practice”. 
But the worst was yet to come. “In a modern, American, market oriented society male circumcision 
                                                      
8 Here, Hill and Denniston repeat word for word a sentence from an article by Ntozi (1999, 99) that puts forward 
a measured position on MC and recommends proceeding to RCTs.  
9 Consulted on the Internet site: http://www.cirp.org/library/ethics/hellsten1/ (Accessed March 17, 2010) 
10 The italics are the author’s, to emphasize the terms used for denouncing a well-hidden conspiracy. 
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became a form of commercial exploitation of children when physicians, in cooperation with 
transnational biotechnology corporations, looked for the sales of marketable and economically 
profitable products made from harvested human foreskins that could further be used in the 
pharmaceutical industry”. Medicine is in league with the powerful and dangerous pharmaceutical 
industry in an illegal trade. And this in the name of a science without ethical bounds that “can be a 
double edge sword that readily lends itself as an alibi for strongly held preferences and cultural 
biases”.  
For Van Howe et al. (2005), epidemiological research on MC wrongfully depicted itself as scientific. 
"Several opinion pieces published in the medical literature have been portrayed as 
‘studies’…Scientific efforts to understand, contain and prevent HIV infection are more likely to be 
successful when the scientists involved in this endeavour can gather and analyze data objectively and 
rationally rather than use AIDS as yet another excuse to promote an old blood rite“ (264). 
Researchers, again supposedly circumcised themselves and considering “their incomplete penis…[as] 
superior to the intact penis” (ibid.), were accused of proselytising in favour of a “barbaric” practice. 
“Should healthy body parts be amputated to conform to cultural and religious practices of scientists 
from outside cultures?” (ibid., emphasis added) In their determination to combat MC, its opponents 
advanced arguments without proof, derived from conspiracy theory, or even based on xenophobia and 
racism. 
After the RCTs: back to “real life”  
As the "gold standard" of medical research11, the RCTs was expected to put an end to debate, at least 
concerning its scientific aspects, since issues of implementation and acceptability may widen the gap 
between efficacy and efficiency. They constitute a working model where researchers can exercise 
maximum control. In the real world, things could be very different. The publication of the RCTs gave 
rise to numerous letters where critics repeated the same arguments and continued to question the 
                                                      
11 "Because the randomized trial and especially the systematic review of several randomized trials is so much 
more likely to inform us and so much less likely to mislead us, it has become the 'gold standard'  for judging 
whether a treatment does more harm than good" (Sackett et al., 1996, 72). 
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methodology. The detractors of MC would not cease their struggle. Their goal was henceforth to slow 
down or even prevent the scaling up that was to be undertaken. 
Circular arguments against MC 
The criticism was focused on the quality of evidence. The RCTs took place over a short period. What 
is the impact of MC over the long term? They were accompanied by very intense follow-up and 
counseling. What would happen when these conditions were no longer present? Garenne (2006) 
questioned whether the effects of MC could be maintained over the long term, using the analogy of 
insufficiently safe contraceptive methods. According to him, the 60% protection shown by Auvert et 
al. (2005) only represents a decrease in the annual risk. MC will have less impact on HIV infection 
after several years. 
Arguments against MC repeated criticisms from before RCTs (Potterat et al., 2006) as though 
evidence was not valid. “Male circumcision is not the vaccine we are looking for” stated Green et al. 
(2008) who also made an appeal to the “real world” and the “long-term” in their indictment of MC. 
“Thousands of African men now line up to get circumcised in the mistaken belief that it will save 
them from HIV […] The public is misled; false hope is promoted from uncertain conclusions” (193, 
emphasis added). The world health community should scrutinize the data and examine “several other 
factors that might have influenced and skewed the results” (ibid.), especially the supposed high 
proportion of non-sexual transmission. MC is dangerous because of contaminated medical 
instruments, exposure to blood, a false sense of security, and risk compensation behaviours. African 
males12 would be too happy to do without condoms and trust an erroneous message about protection. 
MC would decrease the number of Langerhans cells, which, it is supposed, protect against 
transmission by attacking HIV. Myers and Myers (2008) again condemned a pro-circumcision lobby 
impatient to achieve their ends by the promotion of a license for unprotected sex 
A rejoinder emanated from numerous experts —academicians, members of international organizations 
and major foundations, "surprised at the degree of resistance to something which seems to them both 
                                                      
12 This all-encompassing term is repeated several times in the article. It evokes the stereotypes with regard to 
their difficulty in controlling their sexuality.  
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self-evidently good  and worthwhile, and also entirely consistent with the 'scientific' biomedical 
paradigm within which they operate" (Dopson et al., 2003, 317). Wamai et al., 2008, restated the fact 
that scientific evidence was “overwhelming”, that the HIV epidemic was devastating and the many 
other prevention strategies disappointing; early termination of the RCTs was because of the high level 
of efficacy of MC; the data were consistent and that the observed effects were “virtually identical to 
that seen in many previous observational studies”(400). South African, Kenyan and Ugandan cohorts 
are being followed up. “There is no reason why the protective effect of foreskin removal would 
decline over time” (ibid.), and there is no increase in reported risky behaviour. Addressing the 
statement that many infections were not due to heterosexual contacts, the authors replied that “this 
theory has been repudiated by the WHO and virtually all reputable scientists” (ibid.). They repeated 
that no serious or permanent complications of MC were reported in the RCTs, designed to control for 
confounding factors. They indeed adhered to ethical rules and “it is unethical to deny safe MC services 
in high prevalence settings” (401). In conclusion, “as more and more people in sub-Saharan Africa 
become needlessly infected with HIV, the time has come for urgent and decisive leadership, not 
circular and unscientific arguments about an intervention whose efficacy has been proven beyond a 
reasonable doubt.” (403).  
The social sciences: an added dimension? 
In 2007, a review meeting13 was organized at Montreux by the WHO and UNAIDS to compare 
different points of view, notably those of sociologists and anthropologists. Many participants were 
opposed to MC, and did their part in fuelling controversy. If the research evidence was clear, 
consensus was far from achieved (Berer, 2007).  
Niang and Boiro (2007) emphasized the complexity of the social and symbolic meanings of MC in 
West Africa: Senegal and Guinea-Bissau. It has a sacred dimension of spiritual purity as well as a 
sacrificial function. The foreskin is considered a source of disease and malediction. The initiation 
during which MC is carried out is a kind of death followed by resurrection, and a spiritual preparation. 
Men circumcised at the same time are strongly bound together. It is a period of sexual education 
                                                      
13 www.who.int/hiv/pub/malecircumcision/meetingreport_nov07/en/index.html/ (Accessed March 17, 2010) 
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aiming to instil temperance. Is it possible to reconcile these meanings with an alien public health 
perspective? 
Reacting to the fact that MC is “just a snip”, as it was described by a participant in a former 
WHO/UNAIDS meeting, Aggleton (2007) maintains that “few if any investigations contain robust 
controls for confounding factors such as social background, sexual behaviour or penile hygiene.” (19) 
The strengthening advocacy in favour of MC is based on collusion between public health and social 
control. Since prevention programs have been failures, he argues, there is a backlash to biomedical 
acts and moral constraints. The results of the RCTs should be criticized for faulty science. “Evidence 
from recent trials, which at the very least requires continued scientific scrutiny, is now trumpeted as 
'truth'. Opponents… have been silenced and marginalized under the onslaught. Curious alliances have 
arisen between clinicians, advocates, religious leaders and moral entrepreneurs” (20). Such statements 
are very much in line with a frequent position taken by opponents of MC, based on the revelation of a 
conspiracy. 
Dowsett and Couch (2007) again took up the arguments of the staunch opponents of MC. They evoked 
the “euphoria” of participants at the international conference in Toronto in 2006, while “many were 
less sanguine” (34) and pushed aside, notably the sociologists and anthropologists who were “sceptical 
about the narrow form of "science" being touted as the only form of evidence needed […] The 
clamour for circumcision silenced many questions, overrode any misgivings and swept sceptics to the 
sidelines” (ibid.). MC is a discriminatory procedure promoted as an “African solution”. It would 
surely lose its benefits in real world settings. The methodology of the RCTs is also disputed: findings 
were taken out of context, the double-blind was impossible, the counselling intensive. The adverse 
effects of MC will develop over time. It is necessary to remain “wary of the indecent haste with which 
the discussion about MC has been swept up in a tide of enthusiasm based on only one, albeit 
significant, part of the evidence base needed for recommending such a radical public health initiative” 
(42). 
Other participants at this meeting envisaged the practical details and the difficulties of MC scaling up. 
Gruskin (2007) noted that WHO and UNAIDS had not explained what an appropriate MC was, since 
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that operation is characterized by numerous variations. He worried that circumcised men would not 
follow preventive recommendations. Buvé et al. (2007) warned against precipitation and advised to 
“hurry up slowly” (Festina Lente), considering that “the biggest challenge is how to deliver a complex 
prevention package that combines a surgical procedure with a behaviour change intervention”(58). 
How could MC be practiced under proper conditions in insufficient health services? “The biggest 
bottleneck when going to scale with MC will be the lack of human resources” (59).  
Preparing the scaling up 
WHO and UNAIDS, and other organizations — notably, the US President Emergency Plan for AIDS 
relief (PEPFAR), the Bill and Melinda Gates Foundation — became strongly involved when the three 
RCTs produced converging data. It became essential to set up policies of preventive MC in African 
countries where the epidemic was very active, with necessary safety precautions while respecting 
human rights. Hallett et al. (2008) recommend combining MC, motivation to change behaviours and 
antiretroviral treatments (ART), because of the synergy of their effects. According to Podder et al., 
(2007), “the combined use of male circumcision and ART is more effective in reducing disease burden 
than the combined use of male circumcision and condoms for a moderate condom compliance rate” 
(2447). The protective effects of MC were so marked that men will have to take a lot of risks in order 
to cancel them out (Waver et al., 2005). The prevention of millions of infections among men was 
expected, and also among women in the long term, through the mechanism of herd immunity 
(Nagelkerke et al., 2007; White et al., 2008). The protection from STIs afforded by MC will also have 
to be taken into account, since it lowers the risk of HIV infection. Moreover, because of the early 
termination of the RCTs, evaluation at the population level may be inaccurate and underestimate the 
incremental level of impact, which may be larger at the population level and over a longer time scale 
when coverage increases (Boily et al., 2008). 
Between July and November 2006, consultation meetings and task forces were organized by WHO 
and UNAIDS with local authorities and key actors in many countries of Central and Southern Africa14. 
                                                      
14 The minutes of these meetings are available on the site: http://www.who.int/hiv/pub/malecircumcision/en/ 
(Accessed March 17, 2010) 
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In December 2006, a general meeting was held in Geneva15. The aim was to identify countries where 
MC was little practiced and where the prevalence of HIV was high, and to get them involved in 
prevention policies using MC. A brochure16, “Male circumcision, Africa’s unprecedented 
opportunity”, repeats an estimation by Williams et al. (2006): MC has the potential to avert about 5.7 
million new HIV infections and 3 million deaths over 20 years in sub-Saharan Africa. Strategy 
manuals described the various aspects of scaling up17. Guidelines explained circumcision techniques. 
Surgical kits were developed. It was also necessary to determine needs for research and information in 
order to ensure a successful scaling up, to determine what local human resources were available and to 
train medical personnel. How to get the support of traditional healers was an issue that needed to be 
tackled as well.  
“What else do we need to know?” asked Muula (2007) in a cautionary note, since "taking the language 
of epidemiology and applying it to individuals is extremely problematic" (363). There were numerous 
calls for levelheadedness. “The excitement the results of these trials will surely generate should not 
cause us to forgo true diligence in investigating whether or how the clinical evidence can be translated 
into routine practices” (Newell & Bärnighausen, 2007, 618). The same advice came from Sawires et 
al. (2007): “enthusiasm generated from the three trials might not lead to accelerated scale-up… Strong 
science alone does not result in rapid, widespread roll-out” (708). It would however be unethical not to 
take the preventive opportunities offered by MC seriously (Rennie et al., 2007). It was apparently as 
effective as the vaccine everyone has been looking forward to (Klausner et al. 2008). 
Warnings increased about risk compensation and disinhibition. “Avoiding the sexual dissatisfactions 
of condom use and the desire to have more sex partners are likely to be significant motivations for 
men to seek circumcision” (Kalichman et al., 2007). It is recommended to wait for complete healing 
before resuming sexual activity. An assessment was done in Kenya at Bungoma (Bailey et al., 2008) 
where MC is widely practiced, either in medical facilities or by traditional healers. Unsurprisingly, 
there were more complications when the operation was performed by the latter. Therefore, there was a 
                                                      
15 See: www.who.int/hiv/pub/malecircumcision/meetingreport_dec06/en/index.html/ (Accessed March 17, 2010) 
16 www.who.int/hiv/pub/malecircumcision/Africa_opportunity/en/index.html/accessed 
17 www.who.int/hiv/pub/malecircumcision/op_guidance/en/index.html/ (Accessed March 17, 2010) 
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need for infrastructure, personnel, training, follow-up and an effort at information to avoid the harmful 
effects of MC. Kagumire (2008) was not optimistic concerning the situation in Uganda because of the 
president’s opposition to MC.  
According to the cost estimate by Auvert et al. (2008), substantial expenditures will be needed for the 
first five years of the roll-out of MC in sub-Saharan Africa. But they are offset by the expected health 
benefits. The participation of numerous actors — political leaders, activists, teachers, street leaders, 
churches and health workers— is essential for scaling-up. Political support should be strong and 
continuous. 
A review (Byakika-Tusiime, 2008) concluded there is unequivocal evidence of the positive effects of 
MC. A second Cochrane review (Siegfried et al., 2009) stated that it was no longer necessary to 
continue RCTs on MC, as those already done were reliable. It nevertheless concluded that there was 
greater sexual risk-taking among circumcised men, which contradicts the assertions of the authors of 
the RCTs. In their own secondary analysis, Mattson et al. (2008) show a decrease in risk-taking. 
Moreover, a comparable rate of incidental STIs was observed in the two groups, circumcised or not.  
Epilogue 
Following publication of the RCTs and when the question of scaling up was addressed, caution was 
the appropriate attitude and optimism was measured. However, in the field, things are sometimes 
going faster than wished for by the experts, especially in some of the sub-Saharan African countries 
severely affected by AIDS. However this preventive option requires strong political backing (Katz & 
Wright, 2008). In Swaziland, which has the highest prevalence in the world (26%), the prime minister 
became personally involved in implementing MC and men hurry to be circumcised. With a prevalence 
of 24% among 15-49 year olds, Botswana launched a large program of MC. But other countries, 
especially South Africa (18% prevalence), are more reticent to develop MC.  
Countries suffering the most from the HIV epidemic are at a crossroad. MC is a new prevention tool 
with proven efficacy. It is the only preventive technique that has proved itself since the promotion of 
condoms. But all the difficulties of implementing safe MC, combined with other means of prevention 
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because of its partial efficacy, are now going to be discovered in the field. There are many obstacles, 
from opposition or political inertia to a lack of financial and manpower resources, to disagreement 
among scientists. And acceptance by the public, so often brought up in the literature, does not seem 
the most critical problem. 
Conclusion 
From a scientific perspective, we have followed the slow process of establishing evidence and winning 
adherence to it. “The meaning and validity of scientific evidence is influenced as much by the 
sociocultural characteristics of readers and users as it is by meticulous use of research methods” 
(Berkvits, 1998, 1539). Scientific investigation does not take place in a self-contained world. It is 
tainted with emotions and prejudices: “the appeal to logic and science may fail if the rhetoric does not 
also engage with deeply held values and beliefs” (Dopson et al., 2003, 321). The turmoil in society 
does not stop at the doors to the laboratory. However, as research progresses, its methods get freed 
from parasitical hypotheses, and it concentrates on more limited objects. Nonetheless, even the RCTs 
are not the gold standards scientists are looking for: they raise objections concerning the artificial 
conditions making it possible and the narrowness of their scope (Cartwright, 2007; Lambert, 2006). 
“The design of RCTs […] makes their outcomes difficult to generalize over a diverse and 
heterogeneous patient population” (Mykhalovskyi & Weir, 2004, 1063). We end up at an insoluble 
paradox. How can proof be arrived at if it is not possible to simplify, to cut to the essential? But how 
can we simplify, or make models, without denaturing reality?  
RCTs on MC were a challenge. They transferred a methodology based on drug testing, where the 
double blind was possible and decisive, to a surgical operation. This difficulty has not escaped the 
detractors of MC: it taints the orthodoxy of the investigation. Therefore, reproducibility and the 
accumulation of data became essential since they allowed compensating for biases and for 
idiosyncrasies of the researchers or participants.  
RCTs are supposed to compete with clinical expertise, which has long been the rule in the medical 
arena; expertise that is learned through experience, in face-to-face contact with the patient — an 
approach that does neither use controlled comparison, nor rely on measurement and statistics. In 
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epidemiological studies on MC, do the accumulation and the convergence of data gathered outside an 
experimental context strengthen their reliability? As we have seen, measurement is not considered 
sufficient to substantiate evidence. Experimentation makes it possible to measure under controlled 
conditions, and therefore to limit variability. However, uncertainty remains. “Often, evidence is not so 
clear that there is no room for debate” (Rodwin, 2001, 442). Questions about measurement are 
unchanged: has one measured what it is pertinent to measure? Have the most operational variables 
been selected? Is the procedure adapted to its objective? The scientific controversies are focused on 
these aspects and remain unresolved. While combining measurement with experimentation improves 
the quality of evidence, it remains impossible to remove all uncertainty. Evidence conserves elements 
of uncertainty and subjectivity (Muhlrow and Lohr, 2001). It is founded on a shared frame of 
reference, that is similarities on interpretation, and on the “participants’ receptivity” (Dobrow et al., 
2004, 214). It remains therefore a relative entity (Green, 2000 ; Goldenberg, 2006), open to 
“credibility struggles” (Epstein, 1996) and grounded in a legitimating process that defines which 
approaches and data will be considered relevant (Lambert, Gordon and Bogdan-Lovis, 2006). 
 
Another important  point is the emerging consensus about promotion of MC. In principle, evidence is 
expected to be universal. If recommendations concerning MC were to rely on evidence only, this  
preventive approach should be promoted everywhere, including in Western countries, especially those 
in which  MC is rare. This is not the case. MC is presented as a solution for containing AIDS 
epidemics in Africa, and only there. This may be seen as a biomedical colonialism of a kind, or, at 
least, a patronizing attitude that may hurt recipients of this preventive message. The consensus about 
diffusion of  MC in Africa may thus make the  notion of "evidence" more relative, and even subvert it. 
 
Beyond the scientific arena, the data of the RCTs did not change the most active opponents, those 
physicians who have long fought against the practice of MC. As clinicians, they have difficulty 
accepting epidemiological evidence, especially when they consider such evidence as contrary to their 
own experience. They participate in anti-MC organizations active in the United States and Great 
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Britain, countries where the practice of MC has long been widespread. Their denunciation of the 
barbarous nature of the operation is paired with a latent but noticeable ostracism apparent in recurrent 
innuendos aimed at the advocates of MC for religious motives. 
International organizations became involved following the positive results of the RCTs. In their efforts 
to support a policy of scaling up MC, they had to take into consideration the idiosyncrasies of 
politicians for and against MC. This is one reason why wide differences are observed in reactions of 
sub-Saharan African countries. As for the public, it tries to “vote with its feet”: in countries where the 
prevalence of AIDS is very high, demand is strong but facilities are not able to keep up. This brings us 
to the key question of politicization of evidence, that is the use of evidence to legitimate political 
decisions, as well as to its rhetorical uses. “Much of what is called evidence is, in fact, a contested 
domain, constituted in the debates and controversies of opposing viewpoints in search of event more 
compelling arguments” (Wood et al., 1998, 1735). Evidence is politicized during the complex transfer 
of population-level research onto an individual level. This translation process, several authors have 
pointed out, frequently distorts and subverts the original evidence (Eisenberg, 2001 ; Cartwright, 
2007).  
Evidence has not significantly changed the scope of actors’ positions. Finally, it is “real life” that will 
resolve the question: implementation in the field, encouraged or impeded by political authorities 
convinced or not by research results promoted by international organizations, but also, and doubtless 
especially, by their personal convictions. From a scientific as well as a political point of view, passion 
and prejudice will still prevail. 
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